The online sales and distribution platform of medicines known as Sber Eapteka is preparing to introduce a buy-now-pay-later option for medication purchases. This development, reported by the newspaper Vedomosti, cites two people familiar with the project who spoke on condition of anonymity. The plan is described as a new financing feature designed to make it easier for customers to obtain medicines through installments.
A representative from Sber Pharmacy confirmed the existence of the project to the publication, noting that a dedicated service will be created to support its rollout. This confirmation underscores the company’s intention to build a distinct infrastructure that facilitates installment payments for pharmaceutical products.
Vedomosti suggests the move aims to capture a portion of the market that remains untapped by existing platforms. While several marketplaces provide installment options, these offerings have historically focused on dietary supplements rather than prescription medications. The report implies that the new service could set Sber Eapteka apart by extending financing options to prescription drugs as well.
Despite the potential advantages for consumers, the article indicates that demand for such a service in traditional retail channels has not been consistently high. Market observers point out that consumer behavior in pharmacies often favors immediate payment, especially for essential medicines, which could influence adoption and pricing considerations for the new installment option.
In related industry commentary, Victoria Presnyakova, who serves as the director of the Association of Independent Pharmacies of SRO and as president of the Union of Pharmaceutical Associations, has previously highlighted Russia’s broad reliance on prescription medicines. Her remarks underscore the regulatory and logistical complexities that accompany any expansion of financing for prescription drugs and the importance of ensuring clear patient eligibility criteria and safety protocols.
Additionally, Yan Vlasov, who chairs the Public Council for the Protection of Patients’ Rights and co-chairs the All-Russian Patients’ Union, has noted trends in Russia related to self-medication. His observations emphasize the balance that must be struck between accessible medication options and appropriate medical oversight, particularly for medicines that require professional guidance or monitoring.
Historical discussions surrounding the provision of prescription medications at reduced or no cost have also shaped the policy environment in Russia. Debates in this area reflect ongoing public interest in affordable access to essential therapies, as well as concerns about ensuring that financing mechanisms do not compromise patient safety, treatment effectiveness, or the proper use of prescribed medications.